PubRank

Stuart J Head

Author PubWeight™ 48.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014 9.73
2 Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012 2.78
3 Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol 2013 2.41
4 Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg 2012 1.99
5 Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol 2012 1.80
6 Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 2012 1.74
7 Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J 2012 1.72
8 2014 ESC/EACTS guidelines on myocardial revascularization. Rev Esp Cardiol (Engl Ed) 2015 1.69
9 Survival of surgically treated infective endocarditis: a comparison with the general Dutch population. Ann Thorac Surg 2011 1.57
10 The new EuroSCORE II does not improve prediction of mortality in high-risk patients undergoing cardiac surgery: a collaborative analysis of two European centres. Eur J Cardiothorac Surg 2013 1.55
11 Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease. JACC Cardiovasc Interv 2013 1.42
12 Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. Eur Heart J 2012 1.29
13 Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg 2013 1.24
14 Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature. J Am Coll Cardiol 2013 1.11
15 2014 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention 2015 1.08
16 Long term follow up after surgery in congenitally corrected transposition of the great arteries with a right ventricle in the systemic circulation. J Cardiothorac Surg 2010 0.96
17 Predicting prognosis in cardiac surgery: a prophecy? Eur J Cardiothorac Surg 2012 0.96
18 What the cardiothoracic surgeon wants to know from the radiologist: from X-ray reporting to imaging consultancy and Heart Team membership. Pediatr Radiol 2015 0.95
19 Persistent annual permanent pacemaker implantation rate after surgical aortic valve replacement in patients with severe aortic stenosis. Ann Thorac Surg 2012 0.95
20 Transcatheter aortic valve implantation: 10-year anniversary part II: clinical implications. Eur Heart J 2012 0.93
21 Widening clinical applications of the SYNTAX Score. Heart 2013 0.92
22 Costs for surgical aortic valve replacement according to preoperative risk categories. Ann Thorac Surg 2013 0.87
23 Preoperative beta-blocker usage: is it really worthy of being a quality indicator? Ann Thorac Surg 2011 0.86
24 The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis. EuroIntervention 2012 0.83
25 [2014 ESC/EACTS Guidelines on myocardial revascularization]. Kardiol Pol 2014 0.83
26 A crucial factor in shared decision making: the team approach. Lancet 2011 0.81
27 Appropriate coronary artery bypass grafting use in the percutaneous coronary intervention era: are we finally making progress? Semin Thorac Cardiovasc Surg 2012 0.81
28 Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients. Ann Thorac Surg 2012 0.81
29 What is the evidence allowing us to state that transcatheter aortic valve replacement via the femoral artery is a more attractive option compared to transapical valve replacement? EuroIntervention 2011 0.79
30 Patient selection for transcatheter aortic valve replacement: what does the future hold? Expert Rev Cardiovasc Ther 2012 0.79
31 Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. EuroIntervention 2012 0.78
32 TAVI at institutions without cardiovascular surgery departments: why? EuroIntervention 2014 0.78
33 Single-centre experience with mitral valve repair in asymptomatic patients with severe mitral valve regurgitation. Interact Cardiovasc Thorac Surg 2013 0.75
34 Methodologic issues regarding background mortality in observational studies. J Thorac Cardiovasc Surg 2011 0.75
35 Long-term survival of young patients with coronary artery disease is best realized through surgical revascularization with mammary arteries. J Am Coll Cardiol 2013 0.75
36 Details in a meta-analysis comparing mitral valve repair to replacement for ischemic regurgitation. Eur J Cardiothorac Surg 2012 0.75
37 Nonrandomized data on drug-eluting stents compared with coronary bypass surgery caution with interpretation. J Am Coll Cardiol 2011 0.75
38 Off-pump or on-pump coronary-artery bypass grafting. N Engl J Med 2012 0.75
39 CABG, stents, or hybrid procedures for left main disease? EuroIntervention 2015 0.75
40 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery. Eur J Cardiothorac Surg 2017 0.75
41 Towards excellence in revascularization for left main coronary artery disease. Curr Opin Cardiol 2012 0.75
42 Patient selection for TAVI in 2014: is there a justification for treating low- or intermediate-risk patients? The surgeon's view. EuroIntervention 2014 0.75
43 Multivessel coronary artery disease: quantifying how recent trials should influence clinical practice. Expert Rev Cardiovasc Ther 2013 0.75
44 A meta-analysis on clinical outcomes after transaortic transcatheter aortic valve implantation by the Heart Team. EuroIntervention 2017 0.75
45 Tools and Techniques--Clinical: the transaortic approach through a mini-sternotomy using the self-expandable CoreValve Revalving System. EuroIntervention 2013 0.75
46 VARC endpoint definition compliance rates in contemporary transcatheter aortic valve implantation studies. EuroIntervention 2016 0.75
47 Coronary artery bypass grafting: the past, present, and the future. Eur Heart J 2013 0.75
48 Reply: Incomplete Revascularization in PCI and CABG: When Two Plus Two Does Not Make Four. J Am Coll Cardiol 2016 0.75
49 Arterial grafting and complete revascularization: challenge or compromise? Curr Opin Cardiol 2013 0.75
50 Hierarchical testing of composite endpoints: applying the win ratio to percutaneous coronary intervention versus coronary artery bypass grafting in the SYNTAX trial. EuroIntervention 2017 0.75